1 | ARISTIZABAL A M, CAICEDO L A, MARTíNEZ J M, et al. Clinical xenotransplantation, a closer reality: Literature review[J]. Cir Esp, 2017, 95(2): 62-72. |
2 | NAJARIAN J S. Experimental xenotransplantation: a personal history[J]. Xenotransplantation, 2003, 10(1): 10-15. |
3 | LU T, YANG B C, WANG R L, et al. Xenotransplantation: current status in preclinical research[J]. Front Immunol, 2019, 10: 3060. |
4 | COOPER D K, HUMAN P A, LEXER G, et al. Effects of cyclosporine and antibody adsorption on pig cardiac xenograft survival in the baboon[J]. J Heart Transplant, 1988, 7(3): 238-246. |
5 | U.S.Department of Human and Health.Organ Procurement and Transplantation Network[EB/OL].(2021-01-19)[2021-01-23].. |
6 | 金永勋, 沈星辉, 姜 昊, 等. 异种器官移植研究现状及发展前景[J]. 实用器官移植电子杂志, 2018, 6(2): 136-138. |
7 | COOPER D K C, HARA H, IWASE H, et al. Clinical pig kidney xenotransplantation: how close are we?[J]. J Am Soc Nephrol, 2020, 31(1): 12-21. |
8 | YANG Y G, SYKES M. Xenotransplantation: current status and a perspective on the future[J]. Nat Rev Immunol, 2007, 7(7): 519-531. |
9 | GRIESEMER A, YAMADA K, SYKES M. Xenotransplantation: immunological hurdles and progress toward tolerance[J]. Immunol Rev,2014,258(1): 241-258. |
10 | SATYANANDA V, HARA H, EZZELARAB M B, et al. New concepts of immune modulation in xenotransplantation[J].Transplantation,2013,96(11):937-945. |
11 | DORLING A, LOMBARDI G, BINNS R, et al. Detection of primary direct and indirect human anti-porcine T cell responses using a porcine dendritic cell population[J]. Eur J Immunol, 1996, 26(6):1378-1387. |
12 | HERING B J, WALAWALKAR N. Pig-to-nonhuman primate islet xenotransplantation[J]. Transpl Immunol, 2009, 21(2): 81-86. |
13 | GOLLACKNER B, GOH S K, QAWI I, et al. Acute vascular rejection of xenografts: roles of natural and elicited xenoreactive antibodies in activation of vascular endothelial cells and induction of procoagulant activity[J]. Transplantation, 2004, 77(11):1735-1741. |
14 | SHIMIZU A, YAMADA K, YAMAMOTO S, et al. Thrombotic microangiopathic glomerulopathy in human decay accelerating factor-transgenic swine-to-baboon kidney xenografts[J]. J Am Soc Nephrol, 2005, 16(9): 2732-2745. |
15 | COWAN P J, D’APICE A J. The coagulation barrier in xenotransplantation: incompatibilities and strategies to overcome them[J]. Curr Opin Organ Transplant, 2008, 13(2): 178-183. |
16 | COWAN P J, ROBSON S C. Progress towards overcoming coagulopathy and hemostatic dysfunction associated with xenotransplantation[J]. Int J Surg, 2015, 23(Pt B): 296-300. |
17 | ODA M, SATTA Y, TAKENAKA O, et al. Loss of urate oxidase activity in hominoids and its evolutionary implications[J]. Mol Biol Evol, 2002, 19(5): 640-653. |
18 | IBRAHIM Z, BUSCH J, AWWAD M, et al. Selected physiologic compatibilities and incompatibilities between human and porcine organ systems[J]. Xenotransplantation, 2006, 13(6): 488-499. |
19 | SOIN B, SMITH K G, ZAIDI A, et al. Physiological aspects of pig-to-primate renal xenotransplantation[J]. Kidney Int, 2001, 60(4): 1592-1597. |
20 | YAMADA K, YAZAWA K, SHIMIZU A, et al. Marked prolongation of porcine renal xenograft survival in baboons through the use of alpha1,3-galactosyltransferase gene-knockout donors and the cotransplantation of vascularized thymic tissue[J]. Nat Med, 2005, 11(1): 32-34. |
21 | GRIESEMER A D, HIRAKATA A,SHIMIZU A,et al.Results of gal-knockout porcine thymokidney xenografts[J]. Am J Transplant, 2009, 9(12): 2669-2678. |
22 | SHAH J A, LANASPA M A, TANABE T, et al. Remaining physiological barriers in porcine kidney xenotransplantation: potential pathways behind proteinuria as well as factors related to growth discrepancies following pig-to-kidney xenotransplantation[J].J Immunol Res, 2018, 2018: 6413012. |
23 | SOIN B,OSTLIE D,COZZI E, et al.Growth of porcine kidneys in their native and xenograft environment[J]. Xenotransplantation, 2000, 7(2): 96-100. |
24 | JIANG L, JOBST P, LAI L X, et al. Expression levels of growth-regulating imprinted genes in cloned piglets[J]. Cloning Stem Cells, 2007, 9(1): 97-106. |
25 | FISHMAN J A. Infectious disease risks in xenotransplantation[J]. Am J Transplant, 2018, 18(8): 1857-1864. |
26 | YAMADA K, TASAKI M, SEKIJIMA M, et al. Porcine cytomegalovirus infection is associated with early rejection of kidney grafts in a pig to baboon xenotransplantation model[J]. Transplantation, 2014, 98(4): 411-418. |
27 | SEKIJIMA M, WAKI S, SAHARA H, et al. Results of life-supporting galactosyltransferase knockout kidneys in cynomolgus monkeys using two different sources of galactosyltransferase knockout Swine[J]. Transplantation, 2014, 98(4): 419-426. |
28 | GOLLACKNER B,MUELLER N J,HOUSER S,et al. Porcine cytomegalovirus and coagulopathy in pig-to-primate xenotransplantation[J]. Transplantation, 2003, 75(11): 1841-1847. |
29 | WHITTEKER J L,DUDANI A K,TACKABERRY E S.Human fibroblasts are permissive for porcine cytomegalovirus in vitro[J].Transplantation,2008,86(1): 155-162. |
30 | YAMADA K, SACHS D H, DERSIMONIAN H. Human anti-porcine xenogeneic T cell response. Evidence for allelic specificity of mixed leukocyte reaction and for both direct and indirect pathways of recognition[J]. J Immunol, 1995, 155(11): 5249-5256. |
31 | CHEN G, QIAN H, STARZL T, et al. Acute rejection is associated with antibodies to non-Gal antigens in baboons using Gal-knockout pig kidneys[J]. Nat Med, 2005, 11(12): 1295-1298. |
32 | SACHS D H. A knock-out punch?[J]. Nat Med, 2005, 11(12): 1271. |
33 | LOVELAND B E, MILLAND J, KYRIAKOU P, et al. Characterization of a CD46 transgenic pig and protection of transgenic kidneys against hyperacute rejection in non-immunosuppressed baboons[J]. Xenotransplantation, 2004, 11(2): 171-183. |
34 | MéNORET S, PLAT M, BLANCHO G, et al. Characterization of human CD55 and CD59 transgenic pigs and kidney xenotransplantation in the pig-to-baboon combination[J]. Transplantation, 2004, 77(9): 1468-1471. |
35 | BALDAN N, RIGOTTI P, CALABRESE F, et al. Ureteral stenosis in HDAF pig-to-primate renal xenotransplantation: a phenomenon related to immunological events?[J]. Am J Transplant, 2004, 4(4): 475-481. |
36 | HIGGINBOTHAM L,MATHEWS D,BREEDEN C A,et al. Pre-transplant antibody screening and anti-CD154 costimulation blockade promote long-term xenograft survival in a pig-to-primate kidney transplant model[J]. Xenotransplantation, 2015, 22(3): 221-230. |
37 | IWASE H, LIU H, WIJKSTROM M, et al. Pig kidney graft survival in a baboon for 136 days: longest life-supporting organ graft survival to date[J]. Xenotransplantation, 2015, 22(4): 302-309. |
38 | IWASE H, HARA H, EZZELARAB M, et al. Immunological and physiological observations in baboons with life-supporting genetically engineered pig kidney grafts[J].Xenotransplantation,2017,24(2):e12993. |
39 | NIU D, MA X, YUAN T Y, et al. Porcine genome engineering for xenotransplantation[J]. Adv Drug Deliv Rev, 2021, 168: 229-245. |
40 | ALEXANDRE G P J. Plasmapheresis and splenectomy in experimental renal xenotransplantation[J].Xenograft, 1989(25):259-266. |
41 | KIM S C, MATHEWS D V, BREEDEN C P, et al. Long-term survival of pig-to-rhesus macaque renal xenografts is dependent on CD4 T cell depletion[J]. Am J Transplant, 2019, 19(8): 2174-2185. |
42 | COOPER D K, SATYANANDA V, EKSER B, et al. Progress in pig-to-non-human primate transplantation models (1998-2013): a comprehensive review of the literature[J]. Xenotransplantation, 2014, 21(5): 397-419. |
43 | SAMY K P, BUTLER J R, LI P, et al. The role of costimulation blockade in solid organ and islet xenotransplantation[J]. J Immunol Res, 2017, 2017: 8415205. |
44 | WANG D Y, SALEM J E, COHEN J V, et al. Fatal toxic effects associated with immune checkpoint inhibitors: a systematic review and meta-analysis[J]. JAMA Oncol, 2018, 4(12): 1721-1728. |
45 | ISHIHARA J, ISHIHARA A, POTIN L, et al. Improving efficacy and safety of agonistic anti-CD40 antibody through extracellular matrix affinity[J]. Mol Cancer Ther, 2018, 17(11): 2399-2411. |
46 | DEEKS E D, KEATING G M. Rabbit antithymocyte globulin (thymoglobulin): a review of its use in the prevention and treatment of acute renal allograft rejection[J]. Drugs, 2009, 69(11): 1483-1512. |
47 | GROTH C, L F JVAN GRONINGEN, MATOS T R,et al. Phase I/II trial of a combination of anti-CD3/CD7 immunotoxins for steroid-refractory acute graft-versus-host disease[J]. Biol Blood Marrow Transplant, 2019, 25(4): 712-719. |
48 | SCHULER W, BIGAUD M, BRINKMANN V, et al. Efficacy and safety of ABI793, a novel human anti-human CD154 monoclonal antibody, in cynomolgus monkey renal allotransplantation[J]. Transplantation, 2004, 77(5): 717-726. |
49 | FORNONI A, SAGESHIMA J, WEI C L, et al. Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis[J]. Sci Transl Med, 2011, 3(85): 85ra46. |
50 | TASAKI M, SHIMIZU A, HANEKAMP I, et al. Rituximab treatment prevents the early development of proteinuria following pig-to-baboon xeno-kidney transplantation[J]. J Am Soc Nephrol, 2014, 25(4): 737-744. |
51 | HUSKEY J, RIVARD C, MYINT H, et al. Minimal change disease in graft versus host disease: a podocyte response to the graft?[J]. Clin Nephrol, 2013, 80(6): 469-473. |
52 | OHL K, EBERHARDT C, SPINK C, et al. CTLA4 polymorphisms in minimal change nephrotic syndrome in children: a case-control study[J]. Am J Kidney Dis, 2014, 63(6): 1074-1075. |
53 | SPINK C, STEGE G, TENBROCK K, et al. The CTLA-4+49GG genotype is associated with susceptibility for nephrotic kidney diseases[J]. Nephrol Dial Transplant, 2013, 28(11): 2800-2805. |
54 | TANABE T, WATANABE H, SHAH J A, et al. Role of intrinsic (graft) versus extrinsic (host) factors in the growth of transplanted organs following allogeneic and xenogeneic transplantation[J]. Am J Transplant, 2017, 17(7): 1778-1790. |
55 | GARKAVENKO O, MUZINA M, MUZINA Z, et al. Monitoring for potentially xenozoonotic viruses in New Zealand pigs[J]. J Med Virol, 2004, 72(2): 338-344. |
56 | OLDMIXON B A, WOOD J C,ERICSSON T A,et al.Porcine endogenous retrovirus transmission characteristics of an inbred herd of miniature swine[J]. J Virol, 2002, 76(6): 3045-3048. |
57 | DENNER J, T?NJES R R. Infection barriers to successful xenotransplantation focusing on porcine endogenous retroviruses[J]. Clin Microbiol Rev, 2012, 25(2): 318-343. |
58 | GüELL M. Genome-wide PERV inactivation in pigs using CRISPR/Cas9[J]. Methods Mol Biol, 2020, 2110: 139-149. |
59 | LADOWSKI J, MARTENS G, ESTRADA J, et al. The desirable donor pig to eliminate all xenoreactive antigens[J]. Xenotransplantation, 2019, 26(4): e12504. |